Anti-OMD/ OSAD/ SLRR2C functional antibody
Anti-OMD/ OSAD/ SLRR2C functional antibody for cell culture, ELISA & in-vivo assay
Go to OMD/OMD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1152-Ab-1/ GM-Tg-hg-SE1152-Ab-2 | Anti-Human OMD monoclonal antibody | Human |
GM-Tg-rg-SE1152-Ab-1/ GM-Tg-rg-SE1152-Ab-2 | Anti-Rat OMD monoclonal antibody | Rat |
GM-Tg-mg-SE1152-Ab-1/ GM-Tg-mg-SE1152-Ab-2 | Anti-Mouse OMD monoclonal antibody | Mouse |
GM-Tg-cynog-SE1152-Ab-1/ GM-Tg-cynog-SE1152-Ab-2 | Anti-Cynomolgus/ Rhesus macaque OMD monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1152-Ab-1/ GM-Tg-felg-SE1152-Ab-2 | Anti-Feline OMD monoclonal antibody | Feline |
GM-Tg-cang-SE1152-Ab-1/ GM-Tg-cang-SE1152-Ab-2 | Anti-Canine OMD monoclonal antibody | Canine |
GM-Tg-bovg-SE1152-Ab-1/ GM-Tg-bovg-SE1152-Ab-2 | Anti-Bovine OMD monoclonal antibody | Bovine |
GM-Tg-equg-SE1152-Ab-1/ GM-Tg-equg-SE1152-Ab-2 | Anti-Equine OMD monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1152-Ab-1/ GM-Tg-hg-SE1152-Ab-2; GM-Tg-rg-SE1152-Ab-1/ GM-Tg-rg-SE1152-Ab-2; GM-Tg-mg-SE1152-Ab-1/ GM-Tg-mg-SE1152-Ab-2; GM-Tg-cynog-SE1152-Ab-1/ GM-Tg-cynog-SE1152-Ab-2; GM-Tg-felg-SE1152-Ab-1/ GM-Tg-felg-SE1152-Ab-2; GM-Tg-cang-SE1152-Ab-1/ GM-Tg-cang-SE1152-Ab-2; GM-Tg-bovg-SE1152-Ab-1/ GM-Tg-bovg-SE1152-Ab-2; GM-Tg-equg-SE1152-Ab-1/ GM-Tg-equg-SE1152-Ab-2 |
Products Name | Anti-OMD monoclonal antibody |
Format | mab |
Target Name | OMD |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-OMD benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1152-Ag-1 | Recombinant multi-species OMD/ OSAD/ SLRR2C protein |
ORF Viral Vector | pGMLPm001673 | mouse Omd Lentivirus plasmid |
ORF Viral Vector | vGMLPm001673 | mouse Omd Lentivirus particle |
Target information
Target ID | GM-SE1152 |
Target Name | OMD |
Gene ID | 4958,27047,83717,706272,102154566,102900129,280885,102149475 |
Gene Symbol and Synonyms | OMD,OSAD,SLRR2C |
Uniprot Accession | Q99983,Q9Z1S7,O77742 |
Uniprot Entry Name | OMD_HUMAN,OMD_RAT,OMD_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000127083 |
Target Classification | Tumor-associated antigen (TAA) |
The target: OMD, gene name: OMD, also named as OSAD, SLRR2C. Predicted to be involved in cell adhesion and regulation of bone mineralization. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.